CMAJ • November 8, 2005; 173 (10). doi:10.1503/cmaj/051291.
© 2005 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v174,p353)
Right arrow Correction (v173,p1490)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Babuin, L.
Right arrow Articles by Jaffe, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Babuin, L.
Right arrow Articles by Jaffe, A. S.
Related Collections
Right arrow Ischemic heart disease

Review

Troponin: the biomarker of choice for the detection of cardiac injury

Luciano Babuin and Allan S. Jaffe

From the Cardiovascular Division and Division of Laboratory Medicine, Mayo Clinic and Mayo Clinic Graduate Medical School, Rochester, Minn.

Correspondence to: Dr. Allan S. Jaffe, Cardiovascular Division, Gonda 5, Mayo Clinic, 200 First St. SW, Rochester MN 55905, USA; jaffe.allan{at}mayo.edu

Abstract

It has been known for 50 years that transaminase activity increases in patients with acute myocardial infarction. With the development of creatine kinase (CK), biomarkers of cardiac injury began to take a major role in the diagnosis and management of patients with acute cardiovascular disease. In 2000 the European Society of Cardiology and the American College of Cardiology recognized the pivotal role of biomarkers and made elevations in their levels the "cornerstone" of diagnosis of acute myocardial infarction. At that time, they also acknowledged that cardiac troponin I and T had supplanted CK-MB as the analytes of choice for diagnosis. In this review, we discuss the science underlying the use of troponin biomarkers, how to interpret troponin values properly and how to apply these measurements to patients who present with possible cardiovascular disease.




This article has been cited by other articles:


Home page
 Toxicol SciHome page
J. D. Vassallo, E. B. Janovitz, D. M. Wescott, C. Chadwick, L. J. Lowe-Krentz, and L. D. Lehman-McKeeman
Biomarkers of Drug-Induced Skeletal Muscle Injury in the Rat: Troponin I and Myoglobin
Toxicol. Sci., October 1, 2009; 111(2): 402 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
S. K. Engle, W. H. Jordan, M. L. Pritt, A. Y. Chiang, M. A. Davis, J. L. Zimmermann, D. G. Rudmann, K. M. Heinz-Taheny, A. R. Irizarry, Y. Yamamoto, et al.
Qualification of Cardiac Troponin I Concentration in Mouse Serum Using Isoproterenol and Implementation in Pharmacology Studies to Accelerate Drug Development
Toxicol Pathol, August 1, 2009; 37(5): 617 - 628.
[Abstract] [Full Text] [PDF]

Home page
 jvdiHome page
T. J. Divers, M. S. Kraus, S. A. Jesty, A. D. Miller, H. O. Mohammed, A. R.M. Gelzer, L. M. Mitchell, L. V. Soderholm, and N. G. Ducharme
Clinical findings and serum cardiac troponin I concentrations in horses after intragastric administration of sodium monensin
J Vet Diagn Invest, May 1, 2009; 21(3): 338 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
C. P. Chong, Q. T. Lam, J. E. Ryan, R. N. Sinnappu, and W. K. Lim
Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients
Age Ageing, March 1, 2009; 38(2): 168 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
V. Zabrouskov, Y. Ge, J. Schwartz, and J. W. Walker
Unraveling Molecular Complexity of Phosphorylated Human Cardiac Troponin I by Top Down Electron Capture Dissociation/Electron Transfer Dissociation Mass Spectrometry
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1838 - 1849.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
C. Simon, F. Capuano, A. Roscitano, U. Benedetto, C. Comito, and R. Sinatra
Cardiac Troponin I vs EuroSCORE: Myocardial Infarction and Hospital Mortality
Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 97 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, A. H.B. Wu, A. S. Jaffe, F. S. Apple, R. L. Jesse, G. L. Francis, D. A. Morrow, L. K. Newby, J. Ravkilde, W.H. W. Tang, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure
Clin. Chem., December 1, 2007; 53(12): 2086 - 2096.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Qiu, E. P. Ferrell, N. Nolan, B. H. Phelps, R. Tabibiazar, D. H. Whitney, and E. A. Nalefski
Fluorescence single-molecule counting assays for high-sensitivity detection of cytokines and chemokines.
Clin. Chem., November 1, 2007; 53(11): 2010 - 2012.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. A. Kavsak, A. R. MacRae, G. E. Palomaki, A. M. Newman, D. T. Ko, V. Lustig, J. V. Tu, and A. S. Jaffe
Health Outcomes Categorized by Current and Previous Definitions of Acute Myocardial Infarction in an Unselected Cohort of Troponin-Naive Emergency Department Patients
Clin. Chem., November 1, 2006; 52(11): 2028 - 2035.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

EXPLAIN FOR A FIGURE
JUAN F AGUDELO URIBE
CMAJ, 31 Jul 2007 [Full text]
Thank you.
Allan S Jaffe, M.D.
CMAJ, 2 Aug 2007 [Full text]